A comprehensive review of the latest research has concluded that nicotine vapes offer the best chance for smokers to stop successfully, outperforming traditional nicotine replacement therapies such as patches and gum, as well as cessation pills.
Evidence and comparisons
The review pooled and assessed recent studies comparing different quitting aids and found that people using nicotine-containing e-cigarettes were more likely to achieve abstinence than those relying on other licensed therapies. According to the authors, this represents the most current picture of how vaping products compare with established nicotine replacement therapies and medications.
What the review covered
Reviewers drew on the most up-to-date body of evidence available to evaluate effectiveness across a range of products designed to help smokers quit. Their synthesis focused on direct comparisons with commonly used nicotine replacement methods and prescription medications, concluding that e-cigarettes provide a higher rate of cessation in those studies.
Implications for health policy and clinical practice
The findings may influence clinicians, public-health bodies and policymakers weighing treatment options for people who want to quit. If taken into account, the review could prompt reconsideration of guidance offered to smokers about the relative merits of different cessation aids.
Caveats and next steps
While the review highlights greater short- to medium-term success with nicotine vapes, the authors and observers say continued monitoring of long-term outcomes and safety is important. Further research and careful policy discussion will be needed to balance the cessation benefits against any potential risks as more evidence accumulates.